ArticleCells2024
Associations of Plasma Glutamatergic Metabolites with Alpha Desynchronization during Cognitive Interference and Working Memory Tasks in Asymptomatic Alzheimer's Disease.
Vincent Sonny Leong, Jiaquan Yu, Katherine Castor, Abdulhakim Al-Ezzi, Xianghong Arakaki, Alfred Nji Fonteh
Abstract read
In one paragraphArticle in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Vincent Sonny LeongCognition and Brain Integration Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.
Jiaquan YuBiomarker and Neuro-Disease Mechanism Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.
Katherine CastorBiomarker and Neuro-Disease Mechanism Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.
Abdulhakim Al-EzziCognition and Brain Integration Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.ORCID 0000-0003-1627-2994 Xianghong ArakakiCognition and Brain Integration Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.ORCID 0000-0003-0721-7168 Alfred Nji FontehBiomarker and Neuro-Disease Mechanism Laboratory, Neurosciences Department, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.ORCID 0000-0003-4860-5749 Funding
Cognitive challenge to reveal systemic neurophysiology biomarkers in pre-symptomatic Alzheimer’s diseaseR01AG063857 · NIA · HUNTINGTON MEDICAL RESEARCH INSTITUTES · PI ARAKAKI, XIANGHONG, KLONER, ROBERT A · 2021 to 2025
$3.8MCognitive challenge to reveal presymptomatic Alzheimer's diseaseR56AG063857 · NIA · HUNTINGTON MEDICAL RESEARCH INSTITUTES · PI ARAKAKI, XIANGHONG, HARRINGTON, MICHAEL GORDON · 2019 to 2019
$513kNational Institute of Health R56AG063857NIA NIH HHS R01 AG063857R01 R01AG063857
6 · The paper itselfAbstract
Electroencephalogram (EEG) studies have suggested compensatory brain overactivation in cognitively healthy (CH) older adults with pathological beta-amyloid(Aβ
Indexed as
Alzheimer DiseaseCognitionGlutamic AcidMemory, Short-TermAgedAmyloid beta-PeptidesElectroencephalographyFemaleHumansMaleMiddle Agedtau ProteinsAmyloid beta-PeptidesGlutamic Acidtau ProteinsAlzheimer’s disease (AD)electroencephalogram (EEG)event-related alpha desynchronization (ERD)glutamateglutaminepyroglutamate
Identifiers
PMID38891102
PMCPMC11171970
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390